This OMS member-only opportunity includes more than 120 clinical CE on Demand courses available for one year with 24/7 access for $249. Practice management and coding webinars and on-demand courses are not included. Register here.
Note: After registering for the subscription, you must close and reopen your browser to access. Included courses will be priced at $0. You must add them to your cart and continue through the checkout process.
Questions? Email CEonline@aaoms.org.
Dental implant cases can be complex, and a thorough knowledge of surgical and restorative concepts is needed to ensure predictable outcomes. A prosthetic plan with adequate reverse engineering strategies, proper management of the soft tissue through surgical enhancement procedures, and accurate 3D placement are key to achieving lasting, predictable results. This presentation will establish clear surgical and restorative protocols to obtain successful outcomes. Code: WCE231018R
Human Papillomavirus: Pathogenesis, Transmission, Role in Oropharyngeal Cancer and Cancer Prevention - On Demand Access
Human papillomavirus (HPV) is the one of the most common sexually transmitted infections in the U.S. While there are more than 200 human papillomaviruses, most people who are infected by HPV will clear the virus. However, infections with high-risk, long-lasting strains can result in cancer development. One of the most common sites of HPV-associated cancers is the oropharynx made up of the base of tongue, soft palate, palatine tonsils, lateral and posterior pharyngeal walls. Today, HPV-associated oropharyngeal cancer is one of the fastest-rising cancers in men. In this 60-minute webinar, participants will gain knowledge of the pathogenesis of HPV, including routes of transmission, epidemiology of HPV-associated oropharyngeal cancer – as well as its treatment and prognosis – and the role of vaccination as a preventive measure. Code: WCE230823R
In recent years, there has been a growing interest in the use of psychedelic substances as a potential treatment option for a variety of medical conditions. Regulatory restrictions on research into psychedelics were lifted in 2000, and the first landmark study on psilocybin at Johns Hopkins University was published in 2006. The volume of research has been growing every year. Psychedelics such as psilocybin, lysergic acid diethylamide (LSD) and methylenedioxymethamphetamine (MDMA) have been shown in clinical trials to be effective in treating conditions such as depression, anxiety, PTSD, addiction and end-of-life distress. In recent years, several cities such as Detroit, Seattle and Santa Cruz as well as all of Oregon and Colorado have decriminalized the possession and use of psychedelic substances. The FDA has granted breakthrough therapy designation for psilocybin and MDMA-assisted therapy for certain conditions. As legislation changes and psychedelics move from the underground to the mainstream, the anesthetic, dental and oral and maxillofacial surgery fields will have to adjust. This 60-minute webinar will define psychedelics and explore the risks, benefits and potential place in dentistry and oral and maxillofacial surgery. Code: WCE230726R
Cannabis is the most popular illicit drug worldwide. While the DEA still classifies it as a Schedule I controlled substance, it is now legal in many states – with cannabis use still on the rise in the U.S. This increase is particularly seen in high school and college-age students. OMSs will likely encounter patients who use cannabis, affecting the administration and effects of anesthesia – including local anesthesia, nitrous oxide and intravenous sedation/anesthesia. It is important for OMSs to understand how to manage patients who use cannabis. During this 60-minute webinar, participants will learn the pharmacologic and physiologic effects of cannabis, different intake methods and how cannabis can affect office-based anesthesia. Code: WCE230712R
The Medication Access and Training Expansion (MATE) Act requires practitioners to meet specific training requirements tied to their initial or renewal DEA registration. This 90-minute webinar – which appears to fulfill 1.5 hours of the eight-hour requirement of the MATE Act – provides training on how to treat and manage patients with opioid or other substance use disorders (SUDs), including use of drugs approved by the FDA for the treatment of a substance use disorder. The webinar will address safe pharmacological management of dental pain and screening, brief intervention, and referral for appropriate treatment of patients with, or at risk of developing, opioid or other substance use disorders. The potential clinical implications of patients with SUDs also will be discussed. Code: WCE230621R
Patients with syndromic and non-syndromic craniofacial anomalies are often candidates for midfacial and mandibular osteotomies to address dentofacial deformities and upper airway obstruction. Surgical interventions in this population are more challenging due to complex regional anatomy related to the primary diagnosis or the effects of prior interventions (e.g., distraction osteogenesis in infancy or childhood). This 60-minute webinar will focus on the contemporary use of midface (Le Fort I-III) and mandibular osteotomies in the management of syndromic and non-syndromic craniofacial anomalies, as well as the specific considerations for addressing the complex dysmorphologies seen in this population. Code: WCE230329R
A significant percentage of patients with a cleft lip and/or palate benefit from orthognathic surgery for correction of their dentofacial deformity. Cleft orthognathic surgery is more challenging and complex than non-cleft orthognathic surgery due to the nature of the deformity as well as previous operations. During this 60-minute webinar, participants will learn the special considerations of the various types of cleft populations so they can appropriately plan treatment. Code: WCE230322R
Millions of patients take medications for psychiatric conditions. There is paucity of guidelines for the management of these medications to provide outpatient anesthesia. The pharmacology of psychiatric drugs, adverse effects and drugs interactions with sedatives and general anesthetics will be discussed. There is a significant increase in substance abuse across the United States. The lecture also will focus on the drug abuse patient and the implications on office anesthesia. Code: ODAM22SS18
Utilizing OMSNIC closed case examples, a panel comprised of practicing OMSs and an attorney will illustrate patient safety and risk management principles to help OMS minimize adverse events related to the in-office administration of anesthesia. Code: ODAM22GS03
Reconstruction of orbital fractures is a complex area of maxillofacial surgery. The purpose of this session is to discuss unconventional techniques to add to the oral and maxillofacial surgeon's armamentarium so that the surgeon can be better-equipped to tackle challenging defects. In addition to an introductory review of the traditional approaches, the use of technological adjuncts such as computer planning, custom guides, custom hardware, intraoperative CT and navigation will be covered. Adoption of transantral approaches and how to incorporate that into treatment algorithms also will be reviewed. Code: ODAM22SS55
|Access Date||Quiz Result||Score||Actions|
Clinical CE Subscription
This OMS Member-only opportunity includes more than 100 clinical CE on Demand courses available for one year with 24/7 access for $249. Register here.
AAOMS Members, register for the featured complimentary course: Substance Use Disorders and Anesthesia Management - On Demand Access
Medication Access and Training Expansion (MATE) Act
Visit CEonline.AAOMS.org/MATEAct for a list of AAOMS’s current CE online offerings that appear to count toward the eight hours required by the MATE Act. For a limited time, these courses are offered complimentary to AAOMS Members.